STMN1 and nasopharyngeal carcinoma: EBV-encoded miR-BART6-3p inhibits EBV-associated cancer cell migration and invasion by targeting and down-regulating a novel lncRNA LOC553103, providing a potential novel diagnostic and treatment biomarker for NPC and other EBV-related cancers.277 Through proteomics analysis, stathmin (STMN1) was determined to be affected by EBV-miR-BART6-3p and LOC553103.